300 medicine rose 3%, medicine ETF (512010) trading volume continuously ranked similar to the first type

As of 10: 51, 300 pharmaceutical index rose 3.0%.Among the heavy stocks, Yao Ming Kant rose 4.7%, Hengrui Pharmaceutical rose 5.5%, Mai Rui Medical rose 3.0%, El Ophthalmology rose 0.4%, and Pianzi rose 2.6%.

Medicine ETF (512010) was sold for 500 million yuan in the market, ranking first in a row.At the same time, the net inflow in the past January was about 1.1 billion yuan, and the net inflows since this year is about 6.7 billion yuan.

CICC believes that spine consumables have been collected, and the policy of the pharmaceutical industry is gradually warming.The "National Orthopedic Spinal Consumption Purchase Procurement Procurement results" released, the selection of the spine product lines involved in the listed company involved is better.The bidding rules are scientific and reasonable. Domestic heads have benefited from the improvement of concentration, laying a good foundation for the subsequent healthy development of the industry, leaving sufficient space for companies with product innovation.

- END -